When there’s a health epidemic, here’s how innovation often happens: Lives are tragically lost, then wall-to-wall media coverage leads to public hysteria and then drug companies respond by racing to find treatment. Other public health crises, including the AIDS epidemic, swine flu, and the SARS outbreak have followed this same script—and now it’s Ebola’s turn. As the epidemic continues, killing more than 5,000 people in the process, pharmaceutical companies are now shifting their focus to developing treatments. While there are some promising therapies in the pipeline, health experts say these companies should have made more concerted efforts when Ebola first began killing hundreds of...
↧